Chicago & Midwest + Midwest + Industrial | December 7, 2022

Pfizer will spend $750 million to expand its Kalamazoo, MI manufacturing facility, among the company's largest

Pfizer to Invest $750M for Michigan Plant Expansion

Pfizer Inc. will invest $750 million in its Kalamazoo, MI facility, expanding production and creating 300 new jobs. The investment aims to establish the facility as one of the world’s most technologically advanced and continue to ensure the uninterrupted supply of Pfizer medicines and vaccines. It builds upon Pfizer’s initial investment of $465 million in the Kalamazoo facility and a $120-million expansion announced earlier this year.

“Since 2017, Pfizer has invested $5 billion to support the ongoing growth of our manufacturing leadership in the U.S.” said Albert Bourla, chairman and CEO, Pfizer. “This expansion is part of our blueprint to grow our U.S. manufacturing base, create more manufacturing jobs and help ensure patients everywhere can get the medicines they need.”

One of Pfizer’s largest plants, the Kalamazoo facility is a global supplier of sterile injectable, liquid and semi-solid medicines, as well as active pharmaceutical ingredients, producing more than 144 products.

Connect

Inside The Story

Pfizer

About Paul Bubny

Paul Bubny serves as Senior Content Director for Connect Commercial Real Estate, a role to which he brings 13-plus years’ experience covering the commercial real estate industry and 30-plus years in business-to-business journalism. In this capacity, he oversees daily operations while also reporting on both local/regional markets and national trends, covering individual transactions across all property types, as well as delving into broader subject matter. He produces 15-20 daily news stories per day and works with the Connect team and clients to develop longer-form content, ranging from Q&As to thought-leadership pieces. Prior to joining Connect, Paul was Managing Editor for both Real Estate Forum and GlobeSt.com at American Lawyer Media, where he oversaw operations at both publications while also producing daily news and feature-length articles. His tenure in B2B publishing stretches back into the print era, and he has served as Editor in Chief on four national trade publications. Since 1999, Paul has volunteered as the newsletter editor of passenger rail advocacy groups (one national, one local).